<code id='2E09C2B95B'></code><style id='2E09C2B95B'></style>
    • <acronym id='2E09C2B95B'></acronym>
      <center id='2E09C2B95B'><center id='2E09C2B95B'><tfoot id='2E09C2B95B'></tfoot></center><abbr id='2E09C2B95B'><dir id='2E09C2B95B'><tfoot id='2E09C2B95B'></tfoot><noframes id='2E09C2B95B'>

    • <optgroup id='2E09C2B95B'><strike id='2E09C2B95B'><sup id='2E09C2B95B'></sup></strike><code id='2E09C2B95B'></code></optgroup>
        1. <b id='2E09C2B95B'><label id='2E09C2B95B'><select id='2E09C2B95B'><dt id='2E09C2B95B'><span id='2E09C2B95B'></span></dt></select></label></b><u id='2E09C2B95B'></u>
          <i id='2E09C2B95B'><strike id='2E09C2B95B'><tt id='2E09C2B95B'><pre id='2E09C2B95B'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:7
          After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

          WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

          But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

          advertisement

          The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Gene therapies for deafness raise the question: Do deaf people want a 'cure'?
          Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

          Advancesingenetherapycouldeventually"cure"manyformsofcongenitaldeafness.Thechangeshavemanydeafpeople

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Why patients can’t get everything they want on drug pricing

          AdobeYoudon’thavetobeaneconomisttounderstandthelawofdemand:Thehighertheprice,thelesslikelyacustomeri